Beijing: China has reportedly approved patent for CanSino Biologics Inc’s COVID-19 vaccine — Ad5-nCOV. It is the first patent granted by China for a COVID-19 vaccine.
Saudi Arabia will be carrying out the Phase-III clinical trials for the CanSino vaccine this month.
CanSino is exploring testing the vaccine in Russia, Brazil and Chile as well. CanSino’s Hong Kong shares rose by around 14 per cent on Monday.
Also Read: First Batch Of Russian COVID-19 Vaccine To Roll Out This Month
Jharsuguda: Income-Tax officials reportedly interrogated son of slain BJD leader Naba Kishore Das and brother…
New Delhi: A youngsters slapped Kanhaiya Kumar, the North East Delhi candidate of Congress, while…
Cuttack: The Orissa high court has directed the director of elementary education to submit an…
New Delhi: India and Pakistan on Saturday advised students in Bishkek "to stay indoors" amid…
New Delhi: In a twist to the alleged Swati Maliwal case, Arvind Kejriwal's aide, Bibhav…
New Delhi: 'Taarak Mehta Ka Ooltah Chashma' actor Gurucharan Singh, who had been missing for…
Bhubaneswar: Even as DGP has formed a Special Investigation Team (SIT) to investigate the death…
Agra: The Taj Mahal will never lose its significance and charm. Not without reason is the…